Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: A Radiation Therapy Oncology Group Consensus Panel Contouring Atlas

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 3, 2009, Pages 824-830

  Myerson, Robert J ^a   Garofalo, Michael C ^b   El Naqa, Issam ^a   Abrams, Ross A ^c   Apte, Aditya ^a   Bosch, Walter R ^a   Das, Prajnan ^d   Gunderson, Leonard L ^e   Hong, Theodore S ^f   Kim, J J John ^g   Willett, Christopher G ^h   Kachnic, Lisa A ⁱ  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e MAYO CLINIC   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g UNIVERSITY OF TORONTO   (Canada)

^h DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anal cancer; Conformal pelvic radiation; Contouring guidelines; Intensity modulated radiotherapy; Rectal cancer

Indexed keywords

ANAL CANCER; CONFORMAL PELVIC RADIATION; CONTOURING GUIDELINES; INTENSITY-MODULATED RADIOTHERAPY; RECTAL CANCER;

MAXIMUM LIKELIHOOD; ONCOLOGY; PHYSICAL THERAPY; TARGETS; TUMORS;

RADIOTHERAPY;

ANUS CANCER; ARTICLE; CANCER ADJUVANT THERAPY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS; CONTROLLED STUDY; INGUINAL REGION; INTENSITY MODULATED RADIATION THERAPY; PELVIS FLOOR; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; RECTUM CANCER; TREATMENT PLANNING;

ANUS NEOPLASMS; HUMANS; ILIUM; INGUINAL CANAL; LIKELIHOOD FUNCTIONS; LYMPH NODES; MEDICAL ILLUSTRATION; PELVIS; RADIATION ONCOLOGY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RECTAL NEOPLASMS; RECTUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67349203305     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.08.070     Document Type: Article

References (30)

1. Chen Y.J., Liu A., Tsai P.T., et al. Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: Dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes. Int J Radiat Oncol Biol Phys 63 (2005) 274-281
2. Duthoy W., De Gersem W., Vergote K., et al. Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer. Int J Radiat Oncol Biol Phys 60 (2004) 794-806
3. Guerrero Urbano M.T., Henrys A.J., Adams E.J., et al. Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels. Int J Radiat Oncol Biol Phys 65 (2006) 907-916
4. Kim J.Y., Kim D.Y., Kim T.H., et al. Intensity-modulated radiotherapy with a belly board for rectal cancer. Int J Colorectal Dis 22 (2007) 373-379
5. Menkarios C., Azria D., Laliberte B., et al. Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: A comparison of conventional and IMRT plans. Radiat Oncol 2 (2007) 41
6. Milano M.T., Jani A.B., Farrey K.J., et al. Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: Toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 63 (2005) 354-361
7. Nuyttens J.J., Robertson J.M., Yan D., et al. The influence of small bowel motion on both a conventional three-field and intensity modulated radiation therapy (IMRT) for rectal cancer. Cancer Radiother 8 (2004) 297-304
8. Tho L.M., Glegg M., Paterson J., et al. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: Investigating dose-volume relationships and role for inverse planning. Int J Radiat Oncol Biol Phys 66 (2006) 505-513
9. Salama J.K., Mell L.K., Schomas D.A., et al. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: A multicenter experience. J Clin Oncol 25 (2007) 4581-4586
10. Tsai HK, Hong TS, Willins J, et al. Early clinical outcome in patients treated for anal canal cancer using dose-painted intensity modulated radiation therapy. American Society of Clinical Oncology Gastrointestinal Cancer Symposium, Orlando, FL, January 2008.
11. RTOG 0529: A Phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for reduction of acute morbidity in carcinoma of the anal canal. http://rtog.org/members/protocols/0529/0529.pdf.
12. Gallagher M.J., Brereton H.D., Rostock R.A., et al. A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation. Int J Radiat Oncol Biol Phys 12 (1986) 1565-1573
13. Myerson R., and Drzymala R. Technical aspects of image-based treatment planning of rectal carcinoma. Semin Radiat Oncol 13 (2003) 433-440
14. Warfield S.K., Zou K.H., and Wells W.M. Simultaneous truth and performance level estimation (STAPLE): An algorithm for the validation of image segmentation. IEEE Trans Med Imaging 23 (2004) 903-921
15. Fleiss J.L. Statistical methods for rates and proportions. 2nd ed. (1981), Wiley, J., New York
16. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
17. Nuyttens J.J., Robertson J.M., Yan D., et al. The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment. Int J Radiat Oncol Biol Phys 53 (2002) 497-503
18. Flam M., John M., Pajak T.F., et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. J Clin Oncol 14 (1996) 2527-2539
19. Ajani J.A., Winter K.A., Gunderson L.L., et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial. JAMA 23 (2008) 299:1914-1921
20. John M., Pajak T., Flam M., et al. Dose escalation in chemoradiation for anal cancer: Preliminary results of RTOG 92-08. Cancer J Sci Am 2 (1996) 205-211
21. Martenson J.A., Lipsitz S.R., Wagner Jr. H., et al. Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): An Eastern Cooperative Oncology Group study. Int J Radiat Oncol Biol Phys 35 (1996) 745-749
22. Baxter N.N., Habermann E.B., Tepper J.E., et al. Risk of pelvic fractures in older women following pelvic irradiation. J Am Med Assoc 294 (2005) 2587-2593
23. Bosset J.F., Collette L., Calais G., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355 (2006) 1114-1123
24. Gerard J.P., Conroy T., Bonnetain F., et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 24 (2006) 4620-4625
25. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004) 1731-1740
26. Mitchell E, Winter K, Mohiuddin M, et al. Randomized Phase II Trial of preoperative combined modality chemoradiation for distal rectal cancer. Proceedings of The American Society of Clinical Oncology. Vol 23. New Orleans, LA; 2004. p. 254.
27. Baglan K.L., Frazier R.C., Yan D., et al. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 52 (2002) 176-183
28. Gunnlaugsson A., Kjellen E., Nilsson P., et al. Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer. Acta Oncol 46 (2007) 937-944
29. Freedman G.M., Meropol N.J., Sigurdson E.R., et al. Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 67 (2007) 1389-1393
30. Roels S., Duthoy W., Haustermans K., et al. Definition and delineation of the clinical target volume for rectal cancer. Int J Radiat Oncol Biol Phys 65 (2006) 1129-1142